Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-05-20

FDA Approved: HEPARIN SODIUM — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Hospira's heparin sodium, indicating a modification to the product's approval (likely labeling or formulation change…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEPARIN SODIUM (HEPARIN SODIUM)

Snippet

SUPPL AP for HEPARIN SODIUM (HEPARIN SODIUM)